Chronic steroid and immunosuppressant therapy in children

Pediatrics in Review

Volumn 25, Issue 12, 2004, Pages 425-434

  Gedalia, Abraham ^a   Shetty, Avinash K ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR; CYCLOSPORIN A; GLUCOSE; GLYCOGEN; HYDROCORTISONE; INFLUENZA VACCINE; LIVE VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACNE; ALOPECIA; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; ASTHMA; AVASCULAR NECROSIS; BONE FRAGILITY; BONE MARROW SUPPRESSION; BRAIN PSEUDOTUMOR; CATARACT; CHOLESTASIS; CHRONIC DRUG ADMINISTRATION; CIRCADIAN RHYTHM; CLINICAL FEATURE; CORONARY ARTERY ATHEROSCLEROSIS; CORTICOSTEROID THERAPY; CROHN DISEASE; DEPRESSION; DERMATOMYOSITIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG ERUPTION; DRUG MEGADOSE; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; GINGIVA HYPERTROPHY; GLAUCOMA; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HEMOLYTIC UREMIC SYNDROME; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTRICHOSIS; IMMUNOMODULATION; IMPAIRED GLUCOSE TOLERANCE; INAPPROPRIATE VASOPRESSIN SECRETION; INFECTION RISK; INFLUENZA; JUVENILE RHEUMATOID ARTHRITIS; LIVER TOXICITY; LUNG FIBROSIS; LYMPHOCYTOPENIA; MEGALOCYTOSIS; MENTAL INSTABILITY; METABOLIC ALKALOSIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYELODYSPLASIA; MYOPATHY; NEGATIVE FEEDBACK; NEUTROPHILIA; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PANCREATITIS; PATIENT MONITORING; PEPTIC ULCER; PNEUMONIA; POLYMYOSITIS; PSYCHOSIS; REVIEW; RHEUMATIC DISEASE; RHEUMATIC FEVER; SKIN BRUISING; SKIN CANCER; STOMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; TERATOGENICITY; TREATMENT INDICATION; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS; WITHDRAWAL SYNDROME; WOUND HEALING IMPAIRMENT;

EID: 10044275547     PISSN: 01919601     EISSN: None     Source Type: Journal    
DOI: 10.1542/pir.25-12-425     Document Type: Review

References (17)

1. American Academy of Pediatrics. Immunization in special clinical circumstances: immunocompromised children. In: Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 2000:56-64
2. Ansell BM. Overview of side effects of corticosteroid therapy. Clin Exp Rheumatol. 1991;9:19-20
3. Boumpas DT, Chrousos GP, Wilder RL, et al. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993;119:1198-1208
4. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84:304
5. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol. 1998;25:1995-2002
6. Laredo A, Rodriguez RS, Murillo L. Cataracts after short-term corticosteroid treatment. N Engl J Med. 1972;286:160
7. Loeb JN. Corticosteroids and growth. N Engl J Med. 1976;295:547
8. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med. 2000;342:763-769
9. McFarland E. Immunizations for the immunocompromised child. Pediatr Ann. 1999;28:487-496
10. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992;326:1473
11. Oelkers W. Adrenal insufficiency. N Engl J Med. 1996;335:1206
12. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite element. Science. 1993;259:1161-1165
13. Saag KG, Emkey R, Schnitzer T, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med. 1998;339:292-299
14. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol. 1993;45(suppl):S3
15. Segal BH, Sneller MC. Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am. 1997;23:219-237
16. Stuck AE, Minder CE, Frey EJ. Risk of infectious complications in patients taking glucocorticoids. Rev Infect Dis. 1989;11:954
17. The American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendation for the prevention and the treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum. 2001;44:1496-1503